Anie P. Masilamani

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Synergistic Cytotoxicity of a Toxin Targeting the Epidermal Growth Factor Receptor and the Glycosylated Triterpenoid SO1861 in Prostate Cancer.

Synergistic Cytotoxicity of a Toxin Targeting the Epidermal Growth Factor Receptor and the Glycosylated Triterpenoid SO1861 in Prostate Cancer.

Journal: Journal of Cancer
Published: April 27, 2023

Enhanced cytotoxicity of a Pseudomonas Exotoxin A based immunotoxin against prostate cancer by addition of the endosomal escape enhancer SO1861.

Enhanced cytotoxicity of a Pseudomonas Exotoxin A based immunotoxin against prostate cancer by addition of the endosomal escape enhancer SO1861.

Journal: Frontiers in pharmacology
Published: April 25, 2023

ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma.

ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma.

Journal: Life science alliance
Published: February 04, 2022

Calpain-mediated cleavage generates a ZBTB18 N-terminal product that regulates HIF1A signaling and glioblastoma metabolism.

Calpain-mediated cleavage generates a ZBTB18 N-terminal product that regulates HIF1A signaling and glioblastoma metabolism.

Journal: iScience
Published: November 11, 2021

Epidermal Growth Factor Based Targeted Toxin for the Treatment of Bladder Cancer.

Epidermal Growth Factor Based Targeted Toxin for the Treatment of Bladder Cancer.

Journal: Anticancer research
Published: June 15, 2021

Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer.

Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer.

Journal: Toxins
Published: September 30, 2020

An Anti-PSMA Immunotoxin Reduces Mcl-1 and Bcl2A1 and Specifically Induces in Combination with the BAD-Like BH3 Mimetic ABT-737 Apoptosis in Prostate Cancer Cells.

An Anti-PSMA Immunotoxin Reduces Mcl-1 and Bcl2A1 and Specifically Induces in Combination with the BAD-Like BH3 Mimetic ABT-737 Apoptosis in Prostate Cancer Cells.

Journal: Cancers
Published: May 12, 2020

Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression.

Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression.

Journal: Molecular cancer research : MCR
Published: December 28, 2016

c-Jun-N-terminal phosphorylation regulates DNMT1 expression and genome wide methylation in gliomas.

c-Jun-N-terminal phosphorylation regulates DNMT1 expression and genome wide methylation in gliomas.

Journal: Oncotarget
Published: June 11, 2016

KLF6 depletion promotes NF-κB signaling in glioblastoma.

KLF6 depletion promotes NF-κB signaling in glioblastoma.

Journal: Oncogene
Published: June 06, 2016

Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression.

Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression.

Journal: The Journal of clinical investigation
Published: December 03, 2013
Showing 1-11 of 11

Last Updated: 09/26/2026